July 2, 2024 DCVMN CEO in the “2nd Edition of The Global Event on Harnessing Private Sector Engagement for Sustainable Vaccine and Pharmaceutical Manufacturing in Africa” Africa DCVMN Advocacy Vaccines & immunization WeConnectToProtect
June 2, 2024 DCVMN CEO Attended a Private Session at the Permanent Mission of France to the UN in Geneva CEO DCVMN Advocacy Sustainable Regional Manufacturing WeConnectToProtect
May 8, 2024 DCVMN Board at the 8th International Symposium on Immunobiologicals in Rio de Janeiro Brazil DCVMN Board developingcountries Vaccines & immunization WeConnectToProtect
April 25, 2024 DCVMN CEO Inaugurating the Vaccine World Forum in Pune CEO developingcountries Vaccines & immunization WeConnectToProtect
April 3, 2024 DCVMN CEO Engagements in Addis Ababa Africa CEO DCVMN Advocacy developingcountries WeConnectToProtect
March 14, 2024 DCVMN Joint Statement with IFPMA and Trade Associations on Biopharmaceutical Industry Commitments DCVMN Advocacy developingcountries Statement WeConnectToProtect
December 15, 2023 Panacea Biotec launches EasyFourPol® in India and receives registration of Valganciclovir Powder for Oral Solution in Germany Global Health Healthcare Milestones Vaccine Equity Vaccines & immunization Vacine Innovation WeConnectToProtect